Baldwin Wealth Partners’s DexCom DXCM Stock Holding History

Baldwin Wealth Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,219	Closed	-$217K	–	245
2025 Q3	$217K	Hold	3,219	–	–	0.01%	223
2025 Q2	$281K	Hold	3,219	–	–	0.02%	190
2025 Q1	$220K	Sell	3,219 -70	-2%	-$5.71K	0.02%	209
2024 Q4	$256K	Hold	3,289	–	–	0.02%	203
2024 Q3	$220K	Hold	3,289	–	–	0.02%	317
2024 Q2	$373K	Sell	3,289 -50	-1%	-$6.32K	0.03%	160
2024 Q1	$463K	Hold	3,339	–	–	0.03%	157
2023 Q4	$414K	Sell	3,339 -66	-2%	-$6.74K	0.03%	161
2023 Q3	$318K	Hold	3,405	–	–	0.03%	188
2023 Q2	$438K	Sell	3,405 -47	-1%	-$5.68K	0.04%	176
2023 Q1	$401K	Hold	3,452	–	–	0.04%	182
2022 Q4	$391K	Buy	3,452 +728	+27%	+$79.9K	0.04%	178
2022 Q3	$219K	Hold	2,724	–	–	0.03%	163
2022 Q2	$203K	Hold	2,724	–	–	0.03%	178
2022 Q1	$348K	Hold	2,724	–	–	0.04%	151
2021 Q4	$366K	Hold	2,724	–	–	0.04%	152
2021 Q3	$372K	Hold	2,724	–	–	0.04%	144
2021 Q2	$291K	Hold	2,724	–	–	0.03%	161
2021 Q1	$245K	Hold	2,724	–	–	0.03%	167
2020 Q4	$252K	Buy	2,724 +180	+7%	+$16.1K	0.03%	150
2020 Q3	$262K	Buy	2,544 +2,400	+1,667%	+$251K	0.04%	142
2020 Q2	$15K	Buy	+144	New	+$12.9K	﹤0.01%	407

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baldwin Wealth Partners's DXCM Position: Q4 2025 in Review

Baldwin Wealth Partners sold out of DexCom (DXCM) in Q4 2025, closing a stake of 3,219 shares — an estimated $217K sold.

Baldwin Wealth Partners first reported a position in DXCM in Q2 2020 and held it in 22 quarters. The position peaked at $463K in Q1 2024. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Baldwin Wealth Partners reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Baldwin Wealth Partners sold 3,219 DexCom shares in Q4 2025, an estimated $217K.
Baldwin Wealth Partners first reported a position in DexCom in Q2 2020 and held it in 22 quarters.
Baldwin Wealth Partners's DexCom position peaked at $463K in Q1 2024.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Baldwin Wealth Partners's 13F filing for Q4 2025, filed 7 Jan 2026.